North American Vaccine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine

NVX 1.385

-0.4%

12:54 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Don W Stone who wrote (316)	3/4/1998 11:14:00 AM
From: Don W Stone	Read Replies (1) of 507

" Fundamentals & FACTS " 1) NVX is a pure play in the fastest moving part of the drug industry. The analyst that follow NVX are projecting 5 year growth at 75%. 2) NVX will get a minimum of their share of the DTaP market. On that bases NVX could be earning well in excess of $1.50 in their first 12 m0nths of marketing CERTIVA IMO. a) SAFETY is going to be a major issue with all drugs from now on . If you don't believe that statement you haven't been following what is really going on right now. I cover that in my next post. NVX has the only SAFE DTaP vaccine. The information that is out there doesn't disclose the whole story but that is in the procees of changing as you will see from what I say in my next post. 3) NVX will get approval for CERTIVA very shortly. 4) There will be one hell of a short squeeze at some point in the near term. They haven't a clue as to what is really going on in the entire drug industry right now. NVX benefits big time from what is really going on. It is this very activity that brought on this last surprise delay with the FDA and CERTIVA approval. Now to my next post.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next